Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
CytoCore announces 70% reduction in net loss for 2005 over previous year
May 18th, 2006
CytoCore, Inc. (MCDG) announced its 2005 year end financial results where the company continues to increase its positive financial momentum with significant improvement in operating results along with the recent announcement of new equity capital to provide for the launch and development of new products. CytoCore significantly reduced its operating loss before interest and dividends for the December 2005 quarter and 2005 fiscal year. The loss for the December 2005 quarter was $68 thousand, a 92% reduction from the $924 thousand loss for the December 2004 quarter. The 2005 fiscal year loss before interest was $1.15 million, a 75% reduction from the $4.724 million loss...
Source: Biotech Business Week (2006-05-18)
|
